[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20010400L - Isokinoliner som urokinaseinhibitorer - Google Patents

Isokinoliner som urokinaseinhibitorer

Info

Publication number
NO20010400L
NO20010400L NO20010400A NO20010400A NO20010400L NO 20010400 L NO20010400 L NO 20010400L NO 20010400 A NO20010400 A NO 20010400A NO 20010400 A NO20010400 A NO 20010400A NO 20010400 L NO20010400 L NO 20010400L
Authority
NO
Norway
Prior art keywords
isoquinolines
urokinase inhibitors
urokinase
inhibitors
Prior art date
Application number
NO20010400A
Other languages
English (en)
Other versions
NO20010400D0 (no
Inventor
Christopher Gordon Barber
Roger Peter Dickinson
Paul Vincent Fish
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB1999/001289 external-priority patent/WO2000005214A2/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO20010400D0 publication Critical patent/NO20010400D0/no
Publication of NO20010400L publication Critical patent/NO20010400L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO20010400A 1998-07-24 2001-01-23 Isokinoliner som urokinaseinhibitorer NO20010400L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9816228.2A GB9816228D0 (en) 1998-07-24 1998-07-24 Isoquinolines
GBGB9908829.6A GB9908829D0 (en) 1998-07-24 1999-04-16 Isoquinolines
PCT/IB1999/001289 WO2000005214A2 (en) 1998-07-24 1999-07-15 Isoquinolines as urokinase inhibitors

Publications (2)

Publication Number Publication Date
NO20010400D0 NO20010400D0 (no) 2001-01-23
NO20010400L true NO20010400L (no) 2001-03-26

Family

ID=10836172

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010400A NO20010400L (no) 1998-07-24 2001-01-23 Isokinoliner som urokinaseinhibitorer

Country Status (39)

Country Link
EP (1) EP1077945B1 (no)
JP (1) JP2002521367A (no)
KR (1) KR20010083137A (no)
CN (1) CN1318059A (no)
AR (1) AR018960A1 (no)
AT (1) ATE230730T1 (no)
AU (1) AU745545B2 (no)
BG (1) BG105252A (no)
BR (1) BR9912374A (no)
CA (1) CA2337247A1 (no)
CO (1) CO5080787A1 (no)
DE (1) DE69904814T2 (no)
DK (1) DK1077945T3 (no)
DZ (1) DZ2852A1 (no)
EA (1) EA200100073A1 (no)
EE (1) EE200100049A (no)
ES (1) ES2189434T3 (no)
GB (2) GB9816228D0 (no)
GT (1) GT199900116A (no)
HK (1) HK1040996A1 (no)
HN (1) HN1999000116A (no)
HR (1) HRP20010059A2 (no)
HU (1) HUP0103665A3 (no)
ID (1) ID26993A (no)
IS (1) IS5789A (no)
MA (1) MA26664A1 (no)
NO (1) NO20010400L (no)
OA (1) OA11578A (no)
PA (1) PA8478901A1 (no)
PE (1) PE20000937A1 (no)
PL (1) PL346022A1 (no)
PT (1) PT1077945E (no)
SI (1) SI1077945T1 (no)
SK (1) SK1062001A3 (no)
TN (1) TNSN99149A1 (no)
TR (1) TR200100222T2 (no)
TW (1) TW530049B (no)
UY (1) UY25663A1 (no)
ZA (1) ZA200100230B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003076391A2 (de) * 2002-03-11 2003-09-18 Curacyte Ag Hemmstoffe der urokinase, ihre herstellung und verwendung
JP4664924B2 (ja) 2003-12-02 2011-04-06 ウーツェーベー ファルマ ゲーエムベーハー 中枢神経因性疼痛の治療のためのペプチド化合物の新規使用
EP1604656A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
EP1604655A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in trigeminal neuralgia
JP5443981B2 (ja) 2006-06-15 2014-03-19 ウーツェーベー ファルマ ゲーエムベーハー 相乗的抗痙攣効果を有する医薬組成物

Also Published As

Publication number Publication date
CA2337247A1 (en) 2000-02-03
SK1062001A3 (en) 2001-11-06
EE200100049A (et) 2002-06-17
SI1077945T1 (en) 2003-04-30
DZ2852A1 (fr) 2003-12-01
EA200100073A1 (ru) 2001-10-22
MA26664A1 (fr) 2004-12-20
TNSN99149A1 (fr) 2005-11-10
AU4528999A (en) 2000-02-14
PE20000937A1 (es) 2000-09-18
AR018960A1 (es) 2001-12-12
ID26993A (id) 2001-02-22
GB9816228D0 (en) 1998-09-23
TW530049B (en) 2003-05-01
CN1318059A (zh) 2001-10-17
PA8478901A1 (es) 2000-09-29
DK1077945T3 (da) 2003-04-22
PL346022A1 (en) 2002-01-14
CO5080787A1 (es) 2001-09-25
JP2002521367A (ja) 2002-07-16
GT199900116A (es) 2001-01-13
GB9908829D0 (en) 1999-06-16
EP1077945A1 (en) 2001-02-28
KR20010083137A (ko) 2001-08-31
ATE230730T1 (de) 2003-01-15
UY25663A1 (es) 2000-03-31
ES2189434T3 (es) 2003-07-01
HUP0103665A2 (hu) 2002-02-28
NO20010400D0 (no) 2001-01-23
AU745545B2 (en) 2002-03-21
EP1077945B1 (en) 2003-01-08
TR200100222T2 (tr) 2001-12-21
DE69904814T2 (de) 2003-04-30
BG105252A (en) 2001-12-29
ZA200100230B (en) 2002-03-01
BR9912374A (pt) 2001-04-17
IS5789A (is) 2000-12-22
HRP20010059A2 (en) 2002-02-28
HN1999000116A (es) 2000-11-11
PT1077945E (pt) 2003-03-31
DE69904814D1 (de) 2003-02-13
OA11578A (en) 2004-07-20
HK1040996A1 (zh) 2002-06-28
HUP0103665A3 (en) 2002-06-28

Similar Documents

Publication Publication Date Title
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
NO20012980D0 (no) Proteaseinhibitorer
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
ATE237329T1 (de) Metalloprotease inhibitoren
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
DK1268481T3 (da) Inaseinkibitorer som terapeutiske midler
NO20004550D0 (no) Enzyminhibitorer
NO992821D0 (no) Ketobenzamider som calpain-inhibitorer
NO996578D0 (no) Urokinase-inhibitorer
NO20004696L (no) Kinoloner som serinproteaseinhibitorer
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
PT1194404E (pt) Inibidores de aspartil-protease
NO20001924D0 (no) Isoquinoliner som urokinase-inhibitorer
NO20012960L (no) Farnesylproteintransferase-inhibitorer
DE59806475D1 (de) Urokinase-inhibitoren
NO20014243D0 (no) Dihetero-substituerte metalloprotease inhibitorer
NO20003814D0 (no) Trombininhibitorer
NO20014875L (no) Promedikamenter for trombin inhibitorer
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
DE60024101D1 (de) Enzyminhibitoren
DK1075471T3 (da) Idolylderivater som serotonerge midler
DK1077945T3 (da) Isoquinoliner som urokinaseinhibitorer
NO20011654L (no) Benzamidderivater som trombininhibitorer
NO20006314D0 (no) Prenyltransferase-inhibitorer
FI20001808A (fi) Uusi entsyymi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application